期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

卡维地洛治疗慢性充血性心力衰竭40例临床观察

Clinical Efficacy of Carvedilol on Treatment of 40 Cases with Chronic Heart Failure
下载PDF
导出
摘要 目的观察卡维地洛治疗慢性充血性心力衰竭的临床疗效。方法40例慢性充血性心力衰竭患者随机分为对照组和治疗组各20例。对照组仅常规抗心衰治疗,治疗组在常规治疗的基础上加用卡维地洛,治疗16周观察NYHA分级、心电图变化。结果在常规治疗基础上加用卡维地洛较一般常规治疗在改善心功能及心电图方面效果显著。结论卡维地洛治疗慢性充血性心力衰竭安全有效。 Objective To study the effect of Carvedilol in the treatment of chronic heart failure（CHF）. Methods 40 patients were divided into two groups： treatment group and control group. The patients in treatment group were treated with common therapy combining with Carvedilol for sixteen weeks. Before and after treatment,NYHA class ECG changes were observed and evaluated. Results Comparing treatment group with control group,the effect in improving NYHA and ECG was better. Conclusion Carvedilol is effective and safe in CHF patients.
作者 杨瑞
机构地区 洛阳市商业职工医院
出处 《河南科技大学学报（医学版）》 2007年第2期108-109,共2页 Journal of Henan University of Science & Technology:Medical Science
关键词 慢性充血性心力衰竭 Β受体阻滞剂 卡维地洛 chronic heart failure ardenergic receptor carvedilol
分类号 R541.61 [医药卫生—心血管疾病]
  • 相关文献

参考文献4

二级参考文献33

  • 1The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure [ J ]. N Engl J Med,1997, 336:525 -533.
  • 2Bertram p, Wilhm R, et al. Eplerenone, a selective Aldosteone bicker, in patients with left ventricular dysfunction after myocardial infarction[J]. N Engl J Med, 2003, 348:1309 -1321.
  • 3Cosin J, Diez J, et al. Torasemide in chronic heart failure: results of the TORIC study[J]. Eur J Heart Fail, 2002, 4:507 -513.
  • 4rLopez B, Querejeta R, et al. Effect of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure[J]. J Am Coil Cardiol, 2004, 43: 2028 - 2035.
  • 5Hunt SA, Baker DW, et al. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult. Executive summary : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [ J ]. Circulation,2001,104:2996 - 3007.
  • 6Remme WJ, Swedberg K, et al. Guidelines for the diagnosis and treatment of chronic heart failure. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology[J]. Eur Heart J, 2001,22:1527 - 1560.
  • 7Pitt B, Poole-Wilson PA, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial-the Losartan Heart Failure Survival Study [ J ]. Lancet,2000, 355:1582 - 1587.
  • 8Cohn JN, Tognoni G, et al. A randomized trial of the angiotensin-receptor blocker Valsartan in chronic heart failure Trial [ J ]. N Engl J Med, 2001, 345:1667 - 1675.
  • 9Pffeffer MA, Swedberg K, et al. Effect of candesartan on morality and morbidity in patients with chronic heart failure: The CHARM-Overall programme [ J ]. Lancet, 2003, 362:759 - 766.
  • 10CIBIS-Ⅱ Investigation and Committee. The cardiac insufficiency Bisoprolol Study Ⅱ( CIBIS- Ⅱ) : a randomised trial [J]. Lancet,1999, 353:9-13.

共引文献73

河南科技大学学报（医学版）
2007年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部